Skip to Main content Skip to Navigation

Tissu adipeux et résistance tumorale aux thérapies ciblées

Abstract : Targeted therapies as tyrosine kinase inhibitors permitted an improvement of breast cancer therapies by targeting HER2. However, resistance has been observed in obèse patients for lapatinib treatment.We reproduced the effect of resistance of breast cancer cells to laaptinib in presence of adipose tissue as observed for other therapies. Tumor cells overexpressing HER2 was partly resistant to lapatinib but also for other tyrosine kinase inhibitors when in contact with adipocyte-conditioned medium. By impnating human adipose tissue nad human tumors in mice, we were able to study rhe resistance of breast tumor cells in vivo.In order to elucidate the mechanism of such resistance, we exposed the adipocytes to several metabolism modulators. The lapatinib-induced cell cytotoxicity was lower for the tumor cells exposed to the conditioned medium from adipocytes earlier exposed to alpha blockers than to the conditioned medium from adipocytes alone. In the same manner, the toxicity was lower for the agonists of alpha-adrenergic receptors , for beta-blockers and for the lipolysis inhibitors. At the opposite, the cytotoxicity was enhanced for tumor cells in contact with the conditioned medium of adipocytes exposed to the agonists of beta adrenergic receptors.At the tumor cell level, the laaptinib-induced cell cycle arrest was reduced for the tumor cells exposed to the conditioned medium regarding the G0/G1 phase. That was verified by the study of the expression of genes involved in the cell cycle progression
Document type :
Complete list of metadatas

Cited literature [266 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Friday, November 2, 2018 - 3:13:06 PM
Last modification on : Friday, October 23, 2020 - 5:03:22 PM
Long-term archiving on: : Sunday, February 3, 2019 - 12:54:55 PM


Version validated by the jury (STAR)


  • HAL Id : tel-01911229, version 1



Aline Geneste. Tissu adipeux et résistance tumorale aux thérapies ciblées. Cancer. Université de Lyon, 2018. Français. ⟨NNT : 2018LYSE1115⟩. ⟨tel-01911229⟩



Record views


Files downloads